603567.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 03:00):

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields...

Stats
Today's Volume	5.97M
Average Volume	5.29M
Market Cap	10.56B
EPS	CNY0.140 ( 2023-10-27 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	20.81
ATR14	CNY0.0210 (0.19%)

Volume Correlation

Long: 0.30 (neutral)

Short: 0.89 (strong)

Signal:(61.356) Same movement expected

Heilongjiang ZBD Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Heilongjiang ZBD Correlation - Currency/Commodity

0.42
( neutral )

0.35
( neutral )

0.00
( neutral )

-0.32
( neutral )

Heilongjiang ZBD Financials

Annual	2022
Revenue:	CNY4.22B
Gross Profit:	CNY744.78M (17.65 %)
EPS:	CNY0.200

Q3	2023
Revenue:	CNY846.33M
Gross Profit:	CNY424.90M (50.21 %)
EPS:	CNY0.140

Q2	2023
Revenue:	CNY1.06B
Gross Profit:	CNY127.38M (12.06 %)
EPS:	CNY0.0956

Q1	2023
Revenue:	CNY1.53B
Gross Profit:	CNY679.42M (44.30 %)
EPS:	CNY0.270

Financial Reports:

No articles found.

Heilongjiang ZBD